175 related articles for article (PubMed ID: 18598280)
21. High prevalence of hepatitis C virus infection in the largest province of Pakistan.
Idrees M; Lal A; Naseem M; Khalid M
J Dig Dis; 2008 May; 9(2):95-103. PubMed ID: 18419643
[TBL] [Abstract][Full Text] [Related]
22. [Seroepidemiological study on hepatitis C virus infection among blood donors from various regions in China].
Tang S
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):271-4. PubMed ID: 7511060
[TBL] [Abstract][Full Text] [Related]
23. Seroprevalence of hepatitis C antibodies in healthy blood donors--a prospective study.
Bagga PK; Singh SP
Indian J Pathol Microbiol; 2007 Apr; 50(2):429-32. PubMed ID: 17883101
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
Lemos LB; Perez RM; Lemos MM; Draibe SA; Silva IS; Silva AE; Ferraz ML
Nephron Clin Pract; 2008; 108(2):c135-40. PubMed ID: 18230916
[TBL] [Abstract][Full Text] [Related]
25. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico].
Valerio-Ureña J; Vásquez-Fernández F; Pérez-Sosa JA; Cortazar-Benitez LF; Chávez-Tapia NC; Ruvalcaba-Rojas OA; Torres-Medina V; Ocejo-Rodríguez A
Gac Med Mex; 2009; 145(3):183-7. PubMed ID: 19685823
[TBL] [Abstract][Full Text] [Related]
26. [Prevalence of and risk factors for hepatitis C in blood donors].
Ladrón-de Guevara L; Gómez N; Vázquez-Cantarell M; García-Méndez S; Di Silvio M
Rev Gastroenterol Mex; 2002; 67(1):11-6. PubMed ID: 12066425
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and trends of hepatitis C virus among blood donors in Antananarivo, from 2003 to 2009.
Randriamanantany ZA; Rajaonatahina DH; Razafimanantsoa FÉ; Rasamindrakotroka MT; Andriamahenina R; Rasoarilalaomanarivo FB; Hanitriniala SP; Herisoa FR; Rakoto-Alson OA; Rasamindrakotroka A
Transfus Clin Biol; 2012 Apr; 19(2):52-6. PubMed ID: 22410302
[TBL] [Abstract][Full Text] [Related]
28. [Investigation of hepatitis G virus prevalence in hemodialysis patients and blood donors in Denizli, Turkey].
Hanci SY; Cevahir N; Kaleli I; Hanci V
Mikrobiyol Bul; 2008 Oct; 42(4):617-25. PubMed ID: 19149083
[TBL] [Abstract][Full Text] [Related]
29. [Epidemiological study of hepatitis C virus (HCV) infection in plasmapheresis and blood donors].
Jin ZL; Chen SQ; Shi ZY
Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Aug; 16(4):234-6. PubMed ID: 7585906
[TBL] [Abstract][Full Text] [Related]
30. [Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction].
Benouda A; Boujdiya Z; Ahid S; Abouqal R; Adnaoui M
Pathol Biol (Paris); 2009 Jul; 57(5):368-72. PubMed ID: 18842351
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy).
Majori S; Baldo V; Tommasi I; Malizia M; Floreani A; Monteiro G; Ferrari A; Accordini A; Guzzo P; Baldovin T
J Travel Med; 2008; 15(5):323-7. PubMed ID: 19006505
[TBL] [Abstract][Full Text] [Related]
32. HCV positivity rate in the seronegative blood donors in China.
Yang Z; Han YX; Jiang JD; Yang Z; Yu YX; Qiu Y
Biomed Pharmacother; 2009 May; 63(4):319-20. PubMed ID: 19246175
[No Abstract] [Full Text] [Related]
33. Determination of alanine aminotransferase in blood donor screening--evidence of its usefulness in the prevention of post-transfusion hepatitis.
Khouri ST; Lopes EP; Perez RM; Figueiredo VM; Lanzoni VP; Silva AE; Ferraz ML
Clin Lab; 2004; 50(5-6):291-4. PubMed ID: 15209437
[TBL] [Abstract][Full Text] [Related]
34. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
[TBL] [Abstract][Full Text] [Related]
36. [HCV genotypes in Polish blood donors in period 1995-2007].
Brojer E; Grabarczyk P; Kopacz A; Potepa A; Medyńska J; Smolarczyk-Wodzyńska J; Letowska M
Przegl Epidemiol; 2008; 62(1):163-9. PubMed ID: 18536240
[TBL] [Abstract][Full Text] [Related]
37. Identified cases of acute hepatitis C from computerized laboratory database: a hospital-based epidemiological and clinical study.
Hung CH; Lu SN; Wang JH; Hung SF; Chen CH; Hu TH; Lee CM; Changchien CS
J Infect; 2008 Apr; 56(4):274-80. PubMed ID: 18346790
[TBL] [Abstract][Full Text] [Related]
38. Safety and outcome of hepatitis B core antibody-positive donors in right-lobe living donor liver transplantation.
Lo CM; Fan ST; Liu CL; Yong BH; Wong Y; Ng IO; Wong J
Liver Transpl; 2003 Aug; 9(8):827-32. PubMed ID: 12884195
[TBL] [Abstract][Full Text] [Related]
39. Do patient-related blood donors represent a threat to the safety of the blood supply?
Pereira A; Sanz C; Tàssies D; Ramírez B
Haematologica; 2002 Apr; 87(4):427-33. PubMed ID: 11940488
[TBL] [Abstract][Full Text] [Related]
40. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005.
Soto-Salgado M; Pérez CM; Burgos-Calderón R; Torres EA; Suárez E
P R Health Sci J; 2009 Mar; 28(1):18-23. PubMed ID: 19266735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
